Sleeping less than 7 hours a night may shorten your life, new study warns
Americans who routinely sleep less than seven hours a night may be shortening their lives, results published in…
Gut microbe metabolite TMA improves blood sugar by shutting down a key inflammatory switch
A microbial metabolite long linked to cardiovascular risk emerges as a surprising ally against metabolic inflammation, revealing how…
Do they affect gut health? – The Irish Times
Walk into a supermarket, and much of what you see – breakfast cereals, frozen meals, processed meats –…
Study reveals the hidden toll of sudden cardiac death in type 1 and type 2 diabetes
A Danish nationwide study shows that people with type 1 and type 2 diabetes face much higher rates…
Noninvasive Raman device tracks blood glucose accurately in under a minute
A shoebox-sized optical device reads glucose directly through the skin in seconds, offering a promising step toward truly…
Higher PFAS levels reduce blood sugar improvements after teen bariatric surgery
A new USC study shows teens with higher blood levels of per- and polyfluoroalkyl substances (PFAS) measured before…
New C-COMPASS software opens spatial proteomics and lipidomics to non-coders
A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of…
Poll: One in eight adults now using Ozempic, Wegovy or similar GLP-1 drugs
CLEVELAND, Ohio — One in eight adults in the United States are now using Ozempic, Wegovy or similar…
Diabetes drugs linked to slower frailty progression in older adults
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2)…
Sudden cardiac death risk is sharply elevated in people with diabetes
The risk of sudden cardiac death is higher both for people with type 1 and type 2 diabetes,…
Sugar alcohol sorbitol may increase the risk of developing steatotic liver disease
Sweeteners such as aspartame, found in Equal packets, sucralose (Splenda), or sugar alcohols are often seen as healthier…
WHO releases first guideline on the use of GLP-1 therapies for treating obesity
To address the growing global health challenge of obesity, which affects more than 1Â billion people, the World Health…